HRAS and cancer: Concerning gene expression results compared to the BBN induced cancer group, FGFR3 and HRAS (oncogenes) showed strong down-regulated expression levels in both BBN treated with artemisinin group and BBN + cisplatin group pre-treated by artemisinin.